HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insoon Chang Selected Research

Heterochromatin

1/2021Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Insoon Chang Research Topics

Disease

5Neoplasms (Cancer)
01/2024 - 07/2010
5Squamous Cell Carcinoma of Head and Neck
01/2017 - 07/2010
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2017
1Infections
10/2023
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Bites and Stings (Sting)
01/2021
1Lymphatic Metastasis
01/2017

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2016
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 01/2016
2trichostatin A (A 300)IBA
01/2016 - 07/2010
2Bortezomib (Velcade)FDA Link
01/2016 - 07/2010
2Histone Deacetylase InhibitorsIBA
01/2016 - 07/2010
2Proteasome InhibitorsIBA
01/2016 - 07/2010
1Lysosomal Membrane ProteinsIBA
01/2024
1Sirolimus (Rapamycin)FDA Link
01/2024
1ChemokinesIBA
10/2023
1CytokinesIBA
10/2023
1Histones (Histone)IBA
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1HeterochromatinIBA
01/2021
1Group IV Phospholipases A2IBA
01/2017
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2017
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2017
1Histone Deacetylase 6IBA
01/2016
1TOR Serine-Threonine KinasesIBA
01/2016
1beta CateninIBA
07/2010
1CaspasesIBA
07/2010
1theasinensin AIBA
07/2010
1Histone Deacetylases (Histone Deacetylase)IBA
07/2010

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2017 - 01/2016
1Therapeutics
01/2024
1Immunotherapy
01/2021